WallStSmart

Clene Inc. (CLNN)vsKellanova (K)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kellanova generates 6431372% more annual revenue ($12.67B vs $197,000). K leads profitability with a 0.1% profit margin vs 0.0%. K earns a higher WallStSmart Score of 50/100 (C-).

CLNN

Avoid

34

out of 100

Grade: F

Growth: 7.3Profit: 2.5Value: 4.0Quality: 6.5
Piotroski: 2/9Altman Z: -28.19

K

Buy

50

out of 100

Grade: C-

Growth: 3.3Profit: 4.0Value: 4.3Quality: 5.3
Piotroski: 5/9Altman Z: 2.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CLNNSignificantly Overvalued (-62.6%)

Margin of Safety

-62.6%

Fair Value

$2.54

Current Price

$3.57

$1.03 premium

UndervaluedFair: $2.54Overvalued

Intrinsic value data unavailable for K.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CLNN3 strengths · Avg: 10.0/10
Revenue GrowthGrowth
233.3%10/10

Revenue surging 233.3% year-over-year

EPS GrowthGrowth
61.4%10/10

Earnings expanding 61.4% YoY

Debt/EquityHealth
-0.9010/10

Conservative balance sheet, low leverage

K0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

CLNN4 concerns · Avg: 2.8/10
Market CapQuality
$45.87M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-1738.0%2/10

ROE of -1738.0% — below average capital efficiency

K4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

Return on EquityProfitability
0.3%3/10

ROE of 0.3% — below average capital efficiency

Profit MarginProfitability
0.1%3/10

0.1% margin — thin

Operating MarginProfitability
0.1%3/10

Operating margin of 0.1%

Comparative Analysis Report

WallStSmart Research

Bull Case : CLNN

The strongest argument for CLNN centers on Revenue Growth, EPS Growth, Debt/Equity. Revenue growth of 233.3% demonstrates continued momentum.

Bull Case : K

K has a balanced fundamental profile.

Bear Case : CLNN

The primary concerns for CLNN are Market Cap, Profit Margin, Piotroski F-Score.

Bear Case : K

The primary concerns for K are Revenue Growth, Return on Equity, Profit Margin. Thin 0.1% margins leave little buffer for downturns.

Key Dynamics to Monitor

CLNN profiles as a hypergrowth stock while K is a value play — different risk/reward profiles.

CLNN carries more volatility with a beta of 0.95 — expect wider price swings.

CLNN is growing revenue faster at 233.3% — sustainability is the question.

K generates stronger free cash flow (359M), providing more financial flexibility.

Bottom Line

K scores higher overall (50/100 vs 34/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Clene Inc.

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of new clean-surface nanotechnology (CSN) therapies. The company is headquartered in Salt Lake City, Utah.

Kellanova

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

The Kellogg Company, doing business as Kellogg's, is an American multinational food manufacturing company headquartered in Battle Creek, Michigan, United States.

Want to dig deeper into these stocks?